Pancreatic cancer is a disease with a very poor prognosis and its etiology
is still largely elusive. The only consistent environmental risk factor is
cigarette smoking. A previous history of pancreatitis or diabetes mellitus
is also considered to be a risk factor: Epidemiological studies have confir
med that relatives of those with pancreatic cancer have an increased risk o
f this malignancy and it has been evaluated that 3-5% of all pancreatic can
cer cases are caused by genetic predisposition to the disease. Usually this
occurs in the setting of a known inherited cancer syndrome caused by mutat
ions in genes such as BRCA1/2 and CDKN2A. Whether or not a true site-specif
ic pancreatic adenocarcinoma syndrome exists is not known. The real challen
ge for the management of high risk patients is to develop new screening met
hods than can identify pre-neoplastic or early neoplastic lesions in a time
ly manner .